EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Matched oligoclonal bands: Diagnostic utility and clinical characteristics

Yoji Hoshina iD, Justin R Abbatemarco, Stefanie J Rodenbeck, Jason T Poon, Suzanne C Liu, M Mateo Paz Soldan, John E Greenlee iD, John W Rose, Lisa K Peterson, Lisa Johnson, Alen Delic, Tammy L Smith und 1 weitere

Annals of Clinical and Translational Neurology · 2024-11 · 11 (11) · 2846-2854

DOI: 10.1002/acn3.52162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 22.10.2024. Verfasst von Yoji Hoshina und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Oligoclonal Bands, Multiple Sclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe patient clinical characteristics associated with matched oligoclonal bands (OCB).

Methods

A retrospective review at the University of Utah examined patients with matched OCB from 2015 to 2020. Clinical data, diagnosis, and outcomes were collected. Patients were classified with either multiple sclerosis (MS), other inflammatory neurologic disorder (other‐IND), or noninflammatory neurologic disorder (NIND).

Results

Of 539 identified patients, 436 (53.4% female) were matched‐only, while 103 (43.7% female) were matched + unique. Patients with matched‐only bands were older (57.4 ± 16 vs. 52 ± 14.2, p < 0.001) and more likely to have a history of autoimmune disease (40.1% vs. 28.2%, p = 0.024) and/or cancer (28.7% vs. 16.5%, p = 0.012). Patients with matched + unique bands were more likely to have CSF pleocytosis (52.4% vs. 25.9%, p < 0.001), high IgG index (52.2% vs. 7.6%, p < 0.001), and an abnormal MRI (86.9% vs. 63.1%, p < 0.001). More than two‐thirds of matched‐only patients had NIND, while 33% and 41.7% of matched + unique patients had MS and other‐IND, respectively. Patients exhibiting matched‐only bands and a high IgG index demonstrated a significantly higher incidence of other‐IND compared to those with matched‐only bands and a normal IgG index (55.6% vs. 30.4%, p = 0.013). While Kaplan–Meier survival curves demonstrated higher mortality in the matched‐only cohort compared to the matched + unique cohort ( p = 0.02), multivariable Cox regression analysis showed this difference was not statistically significant when adjusting for various factors. A history of cancer was the significant predictor of increased mortality risk (Hazard ratio = 3.147, 95% CI [2.196, 4.51]).

Interpretation

Patients with matched only versus matched + unique OCB have distinct clinical profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligoclonal BandsMultiple SclerosisHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAged

Substanzen

Oligoclonal Bands

Autor:innen und Institutionen

  • Department of Neurology, University of Utah, Salt Lake City, Utah, USA.
  • Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Neurosciences, Evergreen Health, Kirkland, WA, USA.
  • Pediatric Neurology Division, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
  • George E. Wahlen Veterans Affairs Medical Center, Salt Lake City, Utah, USA.

ORCID-Profile: Yoji Hoshina, John E Greenlee

Zitieren

APA

Hoshina, Y., Abbatemarco, J. R., Rodenbeck, S. J., Poon, J. T., Liu, S. C., Paz Soldan, M. M., Greenlee, J. E., Rose, J. W., Peterson, L. K., Johnson, L., Delic, A., Smith, T. L., & Clardy, S. L. (2024). Matched oligoclonal bands: Diagnostic utility and clinical characteristics. Annals of Clinical and Translational Neurology, 11(11), 2846-2854. https://doi.org/10.1002/acn3.52162

Vancouver

Hoshina Y, Abbatemarco JR, Rodenbeck SJ, Poon JT, Liu SC, Paz Soldan MM, et al. Matched oligoclonal bands: Diagnostic utility and clinical characteristics. Annals of Clinical and Translational Neurology. 2024;11(11):2846-2854. doi:10.1002/acn3.52162

BibTeX
@article{Hoshina2024,
  author = {Hoshina, Yoji and Abbatemarco, Justin R and Rodenbeck, Stefanie J and Poon, Jason T and Liu, Suzanne C and Paz Soldan, M Mateo and Greenlee, John E and Rose, John W and Peterson, Lisa K and Johnson, Lisa and Delic, Alen and Smith, Tammy L and Clardy, Stacey L},
  title = {Matched oligoclonal bands: Diagnostic utility and clinical characteristics},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  volume = {11},
  number = {11},
  pages = {2846--2854},
  doi = {10.1002/acn3.52162}
}
Kostenlos starten →